A Phase I/II Study to Evaluate the Safety and Efficacy of Vinorelbine With Trastuzumab Emtansine in Pre-Treated HER2-Positive Metastatic Breast Cancer
Phase of Trial: Phase I/II
Latest Information Update: 24 Apr 2017
At a glance
- Drugs Trastuzumab emtansine (Primary) ; Vinorelbine (Primary)
- Indications Breast cancer; Male breast cancer
- Focus Adverse reactions; Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 10 Apr 2017 Planned primary completion date changed from 1 Oct 2021 to 1 Jul 2022.
- 10 Apr 2017 Status changed from not yet recruiting to recruiting.